ANOGX | NRGSX | ANOGX / NRGSX | |
Total Expense Ratio | 0.94 | 0.74 | 127% |
Annual Report Gross Expense Ratio | 0.94 | 0.74 | 127% |
Fund Existence | 9 years | 13 years | - |
Gain YTD | 7.716 | -3.902 | -198% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 4.77B | 8.71B | 55% |
Annual Yield % from dividends | 0.28 | 0.06 | 433% |
Returns for 1 year | 6.65 | -10.12 | -66% |
Returns for 3 years | 48.35 | 5.90 | 819% |
Returns for 5 years | 2.96 | -2.32 | -127% |
Returns for 10 years | N/A | 10.24 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SAGWX | 6.33 | 0.04 | +0.64% |
Touchstone Small Company A | |||
JFNAX | 73.75 | 0.46 | +0.63% |
Janus Henderson Global Life Sciences A | |||
GMCUX | 16.77 | 0.04 | +0.24% |
Goldman Sachs Small/Mid Cap Equity R6 | |||
ABALX | 39.02 | 0.05 | +0.13% |
American Funds American Balanced A | |||
SGQCX | 42.96 | -0.03 | -0.07% |
DWS International Growth C |